GLP-1 medications represent one of the most significant advances in obesity treatment in decades not because theyre a shortcut, but because they make the long, hard work of weight loss biologically possible for people whose bodies have been fighting against it
Jamie DePolo: Okay, and I realize this is just the beginning, and you may not be able to answer this, but I'm wondering, from what I've read, when people take a GLP-1, either for diabetes or to lose weight, they're pretty much on it indefinitely because when they stop, they tend to gain some or all of the weight back
Persistent vomiting can lead to dehydration and electrolyte imbalances
The peptides for hair growth guide covers additional strategies to support and accelerate regrowth
Less common but clinically significant adverse effects include acute pancreatitis, gallbladder disease, hypoglycemia (particularly when combined with insulin or sulfonylureas), acute kidney injury (especially with severe gastrointestinal losses), and changes in heart rate
Accordingly, resmetirom, an approved drug for MASH treatment, decreases LDL-C levels and improves liver fibrosis 41
